Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huayu Sanjie Tablets in Postoperative PVR After Rhegmatogenous Retinal Detachment Surgery
CTR20160832Phase 2Active
- Sponsor
- Grand Beilin Pharmaceutical
- Start
- Nov 2016
- Countries
- 1
01
Overview
A Phase 2 trial of Huayu Sanjie Pian in Proliferative Vitreoretinopathy (PVR), rhegmatogenous retinal detachment (RRD), sponsored by Grand Beilin Pharmaceutical. Started Nov 2016; status: active.
02
Drugs
Huayu Sanjie Pian
03
Conditions
Proliferative Vitreoretinopathy (PVR)rhegmatogenous retinal detachment (RRD)
Beyond the preview
Go deeper on CTR20160832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160832.